YOLFTbeta
Neuraxis, Inc.

Neuraxis, Inc.

NRXS · AMEX · Healthcare / Biotechnology

5.42USD-0.33 (-5.74%)

Price History

Full chart

Market Stats

Previous Close5.75
Open5.60
Day Range5.35 – 5.75
52-Week Range2.21 – 9.33
Volume202.90K
Market Cap92.93M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.74
Dividend Yield0.00%
Beta1.45
50-Day Avg6.51
200-Day Avg6.26

About

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Brian Carrico
  • Employees24
  • Headquarters11611 North Meridian St, Carmel, IN, United States, 46032, USA
  • Websitehttps://neuraxis.com

Leadership

  • Mr. Brian CarricoPresident, CEO & Director · b. 1982
  • Mr. Timothy Robert HenrichsChief Financial Officer · b. 1973
  • Dr. Adrian MirandaSenior VP of Science & Technology and Chief Medical Officer · b. 1970
  • Dr. Thomas CarricoChief Regulatory Officer and Compliance & Privacy Officer · b. 1957
  • Dr. Christopher Robin Brown D.D.S.Founder, Director of Innovation & Director · b. 1954
  • Ryan KuhlmanVice President of Sales
  • Ms. Trisha BaumgardtVice President of Marketing
  • Mr. Behnam Shamsian CPAInvestor Relations

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.93M2.72M2.68M2.46M2.69M3.57M
Growth (%)-+40.98%-1.34%-8.37%+9.18%+32.89%
Cost of Revenue481.09K467.66K297.06K303.35K362.00K562.92K
Gross Profit1.45M2.25M2.39M2.16M2.32M3.01M
Gross Margin75.08%82.81%88.94%87.67%86.52%84.23%
Operating Expense5.57M5.22M5.76M8.82M9.48M10.84M
Operating Income-4.12M-2.97M-3.37M-6.66M-7.16M-7.83M
Operating Margin-213.48%-109.14%-125.61%-270.91%-266.46%-219.37%
EBITDA-3.61M-2.95M-4.33M-9.23M-7.90M-7.67M
EBITDA Margin-187.27%-108.57%-161.11%-375.11%-294.24%-214.81%
Net Income-3.73M-3.03M-4.78M-14.63M-8.24M-7.80M
Net Income Margin-193.04%-111.27%-178.05%-594.57%-306.84%-218.55%
R&D166.80K203.41K225.61K169.31K206.11K493.61K
R&D as % of Total Revenue8.64%7.47%8.40%6.88%7.67%13.83%
Interest Expense75.71K36.93K417.60K5.36M300.71K73.97K
Interest Expense % of Total Revenue3.92%1.36%15.55%217.80%11.20%2.07%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.79M760.48K1.48M509.50K4.76M6.40M
Total Liabilities1.15M1.59M7.05M1.91M2.69M3.00M
Total Equity1.64M-825.66K-5.57M-1.40M2.07M3.40M
Cash1.90M320.86K253.70K78.56K3.70M4.97M
Total Debt311.49K439.27K598.82K224.26K473.40K416.61K
Net Debt-1.58M118.42K345.12K145.70K-3.22M-4.55M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.14M-2.23M-2.30M-6.69M-6.10M-6.43M
Investing Cash Flow-27.72K-1.39K-61.20K-71.78K-27.78K-131.15K
Financing Cash Flow6.05M661.10K2.29M6.59M9.74M7.83M
Capital Expenditure27.72K1.39K61.20K71.78K27.78K31.15K
Free Cash Flow-4.17M-2.24M-2.36M-6.77M-6.13M-6.46M
FCF to OCF100.67%100.06%102.66%101.07%100.46%100.48%

Earnings

Report DateMay 31, 2023Aug 18, 2023Nov 20, 2023Feb 28, 2024May 20, 2024Aug 9, 2024Nov 12, 2024Mar 20, 2025May 12, 2025Aug 12, 2025Nov 10, 2025Mar 19, 2026Apr 14, 2026Aug 11, 2026Nov 9, 2026
EPS Estimate0.000.00-0.17-0.15-0.10-0.05-0.04-0.24-0.19-0.20-0.21-0.24-0.32-
EPS Actual-0.38-1.21-1.35-0.25-0.32-0.42-0.25-0.20-0.33-0.22-0.24-0.10-0.18-0.19-
Surprise---694.12%-69.80%-220.00%-743.20%--612.50%-37.50%-15.79%-20.00%52.38%25.75%40.63%-
Timing-Pre-marketAfter-hours-After-hours---Pre-marketPre-marketAfter-hoursPre-market-Pre-market-

Key Statistics & Ratios

Market Cap92.93M
Enterprise Value83.76M
Trailing P/E0.00
Forward P/E0.00
Price / Sales17.48
Price / Book13.64
EPS-0.74
Book Value0.54
Revenue (TTM)5.32M
Gross Profit (TTM)4.55M
EBITDA-7.61M
Profit Margin-144.44%
Operating Margin-110.16%
Return on Equity-139.76%
Return on Assets-56.21%
Shares Outstanding12.56M
Shares Float8.34M
Beta1.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 11.00
  • Strong Buy
    1